Testing effectiveness (Phase 2)Study completedNCT02398435What this trial is testingTherapeutic Use of Tadekinig Alfa in Adult-onset Still's DiseaseWho this might be right forStill's Disease, Adult-Onset AB2 Bio Ltd. 23
Large-scale testing (Phase 3)Study completedNCT04717635What this trial is testingStudy of Efficacy and Safety of Canakinumab in Japanese Patients With AOSDWho this might be right forAdult Onset Still's Disease Novartis Pharmaceuticals 14
Not applicableEnded earlyNCT00868751What this trial is testingSingle Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic ArthritisWho this might be right forArthritis, Juvenile RheumatoidStill's Disease, Juvenile Onset Tufts Medical Center 1
Not applicableUnknownNCT03651193What this trial is testingMulti-center Registration Study of Adult Onset Still's Disease in Chinese PopulationWho this might be right forAdult Onset Still Disease Second Xiangya Hospital of Central South University 150
Not applicableActive Not RecruitingNCT07151157What this trial is testingTherapeutic Value of Sirolimus in Refractory Adult-Onset Still's DiseaseWho this might be right forAdult-Onset Still's Disease Ruijin Hospital 3
Large-scale testing (Phase 3)Study completedNCT05001737What this trial is testingEvaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLEWho this might be right forMacrophage Activation SyndromeSecondary Hemophagocytic LymphohistiocytosisStill Disease+4 more Swedish Orphan Biovitrum 33
Not applicableLooking for participantsNCT05927454What this trial is testingAcostill ( RaDiCo Cohort) (RaDiCo Acostill)Who this might be right forStill DiseaseStill's Disease, Adult-OnsetStill Disease, Juvenile Onset Institut National de la Santé Et de la Recherche Médicale, France 500
Testing effectiveness (Phase 2)Study completedNCT01033656What this trial is testingTreatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized StudyWho this might be right forAdult-Onset Still's Disease University of Helsinki 23
Not applicableStudy completedNCT03932344What this trial is testingLong-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)Who this might be right forStill Disease, Juvenile Onset Swedish Orphan Biovitrum 306
Not applicableStudy completedNCT06405152What this trial is testingAssessment of Macrophage Activation syndromE in STill's DiseaseWho this might be right forMacrophage Activation SyndromeStill's Disease, Adult-OnsetStills Disease, Juvenile-Onset Swedish Orphan Biovitrum 75
Not applicableStudy completedNCT06992505What this trial is testingAssessment of Macrophage Activation syndromE in STill's Disease in ItalyWho this might be right forMacrophage Activation Syndrome (MAS)Still Disease, Juvenile OnsetStill's Disease, Adult-Onset Swedish Orphan Biovitrum 32
Testing effectiveness (Phase 2)Looking for participantsNCT07203001What this trial is testingA Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's DiseaseWho this might be right forStill´s Disease Novartis Pharmaceuticals 20
Not applicableLooking for participantsNCT06339177What this trial is testingHemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE StudyWho this might be right forLymphohistiocytosis, HemophagocyticSecondary Hemophagocytic LymphohistiocytosisMacrophage Activation Syndrome+1 more National Institute of Allergy and Infectious Diseases (NIAID) 300
Large-scale testing (Phase 3)Ended earlyNCT03265132What this trial is testingEvaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD)Who this might be right forStill's Disease, Adult-OnsetStill's Disease, Juvenile-Onset Swedish Orphan Biovitrum 13
Testing effectiveness (Phase 2)Ended earlyNCT02204293What this trial is testingCanakinumab for Treatment of Adult-onset Still's DiseaseWho this might be right forAdult-Onset Still´s Disease Charite University, Berlin, Germany 36
Testing effectiveness (Phase 2)Study completedNCT03311854What this trial is testingInvestigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)Who this might be right forMacrophage Activation SyndromeLymphohistiocytosis, HemophagocyticArthritis, Juvenile+1 more Swedish Orphan Biovitrum 14
Early research (Phase 1)Study completedNCT05715736What this trial is testingAssessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of APB-R3Who this might be right forStill's Disease, Adult-Onset Syneos Health 31
Not applicableUnknownNCT01952275What this trial is testingObservational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin DiseasesWho this might be right forOther Specified Inflammatory Disorders of Skin or Subcutaneous TissuePyoderma GangrenosumErosive Pustular Dermatosis of the Scalp+25 more University of Zurich 600
Not applicableLooking for participantsNCT03510442What this trial is testingNatural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related ConditionsWho this might be right forStill's Disease, Adult-OnsetSystemic InflammationArthritis+1 more National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 2,000
Large-scale testing (Phase 3)Active Not RecruitingNCT05814159What this trial is testingAnakinra in Japanese Patients With Still's Disease (SJIA and AOSD)Who this might be right forStill's Disease, Juvenile OnsetStill's Disease, Adult-Onset Swedish Orphan Biovitrum 15